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Abstract
Background—We sought to disentangle the contributions of perinatal systemic inflammation
and small for gestational age (SGA) to the occurrence of low Bayley Mental Development Indices
(MDIs) at age 2 years.
Method—We measured the concentration of 25 inflammation-related proteins in blood obtained
during the first 2 postnatal weeks from 805 infants who were born before the 28th week of
gestation and who had MDI measurements at age 2 years and were able to walk independently.
Results—SGA newborns who did not have systemic inflammation (a concentration of an
inflammation-related protein in the top quartile for gestational age on 2 days a week apart) were at
greater risk of an MDI < 55, but not 55–69, than their peers who had neither SGA nor systemic
inflammation. SGA infants who had elevated blood concentrations of IL-1beta, TNF-alpha, or
IL-8 during the first two postnatal weeks were at even higher risk of an MDI < 55 than their SGA
peers without systemic inflammation and of their non-SGA peers with systemic inflammation.
Conclusion—SGA appears to place very preterm newborns at increased risk of a very low MDI.
Systemic inflammation adds considerably to the increased risk.
Corresponding author: Alan Leviton, Children’s Hospital Boston, Au-414, 300 Longwood Avenue, Boston MA 02115-5724,
alan.leviton@childrens.harvard.edu, telephone: 617 355-6491, fax: 617 730-0880.
*Please see Acknowledgments section.
Disclosure: The authors have no conflicts of interest.
NIH Public Access
Author Manuscript
Pediatr Res. Author manuscript; available in PMC 2013 September 01.
Published in final edited form as:
Pediatr Res. 2013 March ; 73(3): 362–370. doi:10.1038/pr.2012.188.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Introduction
Small for gestational age (SGA) occurs more commonly among very preterm newborns than
among their peers born closer to term (1). SGA preterm infants are more likely than their
more appropriately grown peers to have structural abnormalities of the brain (2). They are
also more likely to have multiple expressions of developmental delay/limitations, including
low scores on cognition assessments (3, 4). These abnormalities are compatible with early
direct insults to the brain or disturbances to developmental processes.
Systemic inflammation also places preterm infants at increased risk of functional limitations
and indicators of reduced brain volume (5–13).
In a two-hit model of brain damage, SGA appeared to sensitize neonatal rats to a subsequent
inflammatory stimulus, resulting in more brain damage than seen in control rats following
the same inflammatory stimulus (14). We are not aware of any report of an assessment of
such a two-hit model in extremely low gestational age human newborns. Such an assessment
might help elucidate how much of the brain damage in SGA preterm newborns can be
attributed to growth-restriction, and how much to subsequent inflammation.
Results
Sample description
Of the 805 infants born before the 28th week of gestation who had inflammation-related
proteins measured on two days in perinatal blood spots, a Bayley Scales of Infant
Development assessment at age 2 years and a Gross Motor Function Classification System
score < 1 at 2 years, 11% (N=91) had an MDI < 55, which is approximately 85-fold the
expected 0.13% for a score more than 3 standard deviations below the expected mean (Table
1). Another 85 children had an MDI in the 55–69 range, which places their MDI more than 2
standard deviations below the expected mean, but above the 3 standard deviations criterion.
The sample consists of these 176 children plus their 629 peers with higher MDI scores who
also were able to walk and had proteins measured in perinatal blood spots.
Potential confounders: delivery and placenta characteristics
We sought characteristics and exposures that might distort an assessment of the relationships
between each of the antecedents of interest (i.e., SGA and postnatal systemic inflammation)
and the outcomes of interest, an MDI < 55 and an MDI between 55 and 69, in light of the
contribution of the other antecedents. Women who had severe preeclampsia were more
likely than others to give birth to an SGA infant (55% vs 8% for pre-labor rupture of
membranes and 7% for preterm labor) and to infants with a very low MDI (17% vs 14% for
pre-labor rupture of membranes and 9% for preterm labor) (Table 2). Infants born to these
women were not at increased risk of having persistent or recurring elevated blood
concentrations of inflammation-related proteins. Delivery for a fetal indication was also
associated with both an MDI in the 55–69 range and persistent/recurrent elevated
concentrations of IL-1beta, IL-8, and ICAM-1. Receipt of magnesium for seizure
prophylaxis (a correlate of preeclampsia) was associated with both SGA and an MDI < 55,
but not with elevated concentrations of inflammation-associated proteins. Infants whose
placenta harbored an organism or had histologic inflammation of the membranes or
umbilical cord were less likely than others to have been SGA, but were not at increased risk
of an MDI <55. Those whose placenta and umbilical cord had histologic inflammation were
more likely than others to have elevated concentrations of inflammation-related proteins.
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Potential confounders: characteristics of the newborn
Boys were less likely than girls to be SGA (10% vs 19%) and more likely to have an MDI <
55 and an MDI between 55 and 69 (Table 3). The lower the gestational age, the higher the
rate of very low MDI. SGA infants were more likely than others to have had elevated
concentrations of IL-6, TNF-alpha, IL-8, and ICAM-1 on two separate days during the first
two weeks following birth. The smaller the head circumference at birth, the higher the rate
of very low MDI, and of elevated blood concentrations of inflammation-related proteins on
two separate days.
Potential confounders: postnatal characteristics
Infants who had hyperoxemia, hypercarbia, and acidemia on two of the first three postnatal
days were more likely than others to be SGA, but not appreciably more likely to have a very
low MDI, although newborns with hypercarbia or acidemia were at increased risk of an MDI
in the 55–69 range (Table 4). Newborns who had early postnatal acidemia were more likely
than others to be SGA, and have prominent systemic inflammation. Bacteremia was
associated with both an MDI <55 and with systemic inflammation, but not with SGA.
Infants who were ventilated on days 7, 14 and 21 were more likely than others to have SGA,
low MDIs, and systemic inflammation. MDI in the 55–69 range was minimally associated
with both late bacteremia and ventilation.
Influence of the co-occurrence of SGA and inflammatory stimuli on low MDI
The risk of an MDI < 55 was highest in SGA infants who had bacteremia during the second,
third, or fourth weeks, while the risk of an MDI between 55 and 69 was elevated among
SGA infants who had bacteremia during the first postnatal week (Table 5). The risk of an
MDI < 55 was also elevated in SGA infants who were ventilated on postnatal day 7 or after.
In contrast, however, ventilation did not appear to have a disproportionate effect on SGA
infants.
Odds ratios of a very low or moderately low MDI among children classified by whether or
not they were SGA and by protein concentration elevations
Because we constructed a separate model for each protein, Table 6 displays the results
obtained with 25 separate models.
MDI < 55
Compared to children who had neither SGA, nor an elevated concentration of the individual
protein on two separate days separated by approximately one week (fourth data column),
those with SGA, but without repeatedly high concentrations of an individual protein, had a
risk of an MDI < 55 in the range of 1.7 to 3.8, with most odds ratios significant at p <.01
(third data column) (Table 6). In essence, these infants were at increased risk, regardless of
the protein assessed. Their increased risk is associated with SGA and not with systemic
inflammation. The odds ratios vary for different proteins because the risk of a very low MDI
associated with SGA in these models is influenced by the effect of elevated protein
concentrations on the risk among other infants. In contrast, those SGA babies who had
repeatedly high concentrations of SAA, IL-1β, IL-6, TNF-α, IL-8, MIP-1β, ICAM-1, E-
SEL, and/or IGFBP-1 were at much higher risk of a very low MDI (first data column). Most
of the odds ratios for these children were double those of their SGA peers who did not have
repeatedly elevated concentrations of these proteins (third data column). The risks of a very
low MDI were significantly increased in infants who did not have SGA, but did have
recurrent/persistent elevated concentrations of CRP, SAA, IL-8, ICAM-1, E-SEL, and
VEGF-R2 (second data column). These odd ratios were not as high as those seen in among
SGA infants who had systemic inflammation.
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In separate analyses (not shown), only bacteremia, and not the indication for delivery or
duration of ventilation contributed to the risk of an MDI <55, without appreciably reducing
the risks associated with SGA and indicators of systemic inflammation. The odds ratios for
bacteremia were close to 2.0 and were statistically significant at p < .01. No interaction was
seen between SGA and either bacteremia, delivery indication, or duration of ventilation.
MDI = 55–69
SGA infants who did not have repeatedly high concentrations of an individual protein, were
not at appreciably increased risk of an MDI in the 55 to 69 range (next to last data column).
Among SGA infants who had repeatedly high concentrations of individual proteins, SAA
was the only protein to achieve statistical significance (third data column from the right).
Although repeatedly high concentrations of several proteins were associated with increased
risk of an MDI in the 55–69 range among SGA infants, only MIP-1beta had a statistically
significantly elevated odds ratio (fourth data column from the right).
Discussion
Our main findings are that extremely preterm SGA newborns were at increased risk of a
very low MDI (<55). When they had systemic inflammation in addition to SGA, their risks
were considerably higher than the risks associated with systemic inflammation in infants
who were not SGA at birth or infants without inflammation or SGA. In essence, SGA alone,
or phenomena associated with SGA, appear to place SGA newborns at increased risk, and
this risk is prominently heightened if they were also exposed to prolonged or repetitive
systemic inflammation during the first two weeks after birth.
Limitations and strengths
The weaknesses of our study are those of all observational studies. We are unable to
distinguish between causation and association as explanations for what we found.
Our study has several strengths. First, we selected infants based on gestational age, not birth
weight, in order to minimize confounding due to factors related to fetal growth restriction
(15). Second, we collected all of our data prospectively. Third, examiners were not aware of
the medical histories of the children they examined, thereby minimizing “diagnostic
suspicion bias” (16). Fourth, we have minimized observer variability as best we can in the
assessments of neurodevelopmental functions (17). Fifth, attrition in the first two years was
modest. Sixth, our protein data are of high quality (18), and have high content validity (19–
22).
Maternal and fetal indications for delivery, SGA, and inflammation
Although preeclampsia might not be an inflammatory disorder primarily, many
characteristics and associations link it to inflammatory phenomena (23). Thus, the first hit
might have been exposure to maternal inflammation (24).
SGA infants tended to have higher blood concentrations of IL-6, TNF-alpha, IL-8, and
ICAM-1 on repeated occasions than others. Nevertheless, although 55% of infants born to
preeclamptic women were SGA, they were not more likely than others to have repeated
elevations of blood concentrations of inflammation-associated proteins. In contrast, infants
delivered for fetal indications tended to have prominently elevated concentrations of
IL-1beta, IL-8, and ICAM-1, even though only 38% of these newborns were SGA. Perhaps
the magnesium given to preeclamptic women dampened the inflammatory responses of their
SGA newborns (25).
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SGA, postnatal systemic inflammation, and very low MDI
The odds ratios of an MDI < 55 associated with persistent/recurrent elevated concentrations
of SAA, IL-1beta, IL-6, TNF-alpha, IL-8, ICAM-1, E-Selectin, and IGFBP-1 were
considerably higher among SGA children than among their peers. These observations are
compatible with two possibilities. One is that processes associated with SGA, and processes
associated with systemic inflammation each contribute independently to risk of a very low
MDI. The other is that processes associated with SGA sensitize the brain to the adverse
effects of postnatal inflammation.
Two-hit models of brain damage
“Morbidities associated with preterm delivery appear to be additive to those associated with
fetal growth restriction so SGA, preterm infants may be at great risk for poor
neurodevelopmental outcome” (26). This quote exemplifies the concept of the greater the
number of risk factors, the higher the risk. On the other hand, the heightened risk might not
be additive.
This two-hit model is exemplified by the greater extent of brain damage following
intracerebral lipopolysaccharide (endotoxin) among growth-restricted rats than among rats
that were not growth-restricted (14). In this model, one hit (the inflammatory stimulus,
lipopolysaccharide) is followed by damage, but a previous hit (a process associated with
SGA, or perhaps multiple processes), allows the second hit to result in greater damage than
if the first hit had not occurred. No abnormalities were seen in the brains of the growth-
restricted rat pups not exposed to the inflammatory stimulus. Thus, this model qualifies for
the concept of sensitization, which like preconditioning requires that the first exposure alone
not produce damage (27). This is in contrast to some two-hit models that have the first hit
produce some damage, and the second hit enhance or amplify the damage (28–32).
Why do two-hit models apply to an MDI < 55, but not to an MDI between 55 and 69?
Our two-hit models apply to an MDI more than three standard deviations below the mean,
but not to the less severe reduction of an MDI between two and three standard deviations
below the mean. We are not sure why what we see prominently for an extreme outcome is
not seen less extremely for a less extreme outcome. One possibility is that the set of risk
factors for MDI < 55 differs from those for MDI 55–69. Another possibility is that what we
see are the consequences of a threshold effect.
SGA, inflammation, and adult diseases
The presumed late consequences of SGA, including adult-onset diabetes, obesity,
hypertension, and atherosclerotic disease are associated with inflammation (33). We did not
see evidence of inflammation on the first postnatal day (21). Perhaps what we saw just a few
weeks later is the earliest indication of an intense inflammatory proclivity that accounts for
some of the adult diseases associated with SGA.
Epigenetic mechanisms
Epigenetic mechanisms, which can influence phenotypic plasticity without altering genomic
DNA, have been invoked to explain a wide variety of SGA consequences, including adult
diseases, (33)., as well as inflammatory processes associated with neonatal brain damage
(34). If processes associated with growth restriction in utero account for some of the brain’s
sensitivity to postnatal inflammation, then therapies that interfere with epigenetic processes
might protect the brain (34).
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Choice of potential confounders
Our search for potential confounders of the relationships among SGA, systemic
inflammation, and low MDI was especially difficult because some of them might be in the
causal chain leading from SGA to low MDI. For example, the majority of SGA infants were
born to women who had severe preeclampsia or were delivered for fetal indications. Also,
magnesium was given for seizure prophylaxis, almost exclusively to women with severe
preeclampsia. Indication for delivery and duration of ventilation neither added independent
information about the risk of an MDI < 55, nor altered the odds ratios associated with SGA
or any indicator of systemic inflammation. On the other hand, bacteremia contributed
supplemental information about the risk of a very low MDI without altering contributions of
SGA and indicators of systemic inflammation. These observations support our decision to
present analyses without adjusting for these variables.
We did adjust for gestational age, because this is probably our best indicator of unidentified
correlates of maturity (35). We also adjusted for sex because SGA usually predicts low MDI
differently in each sex (36).
Implications
If our findings are replicated, they will be an example in humans of a two-hit model of brain
damage. Two implications follow from our observations. First, our findings might be simply
explained as an example of an additive model of increased risk, although consideration
should be given to the possibility that the consequences of SGA and systemic inflammation
are more than additive. Second, effective intervention to improve outcome among SGA
infants might be possible even following delivery.
Conclusions
Very preterm SGA newborns appear to be at increased risk of severely limited mental
development, especially if they experienced early postnatal systemic inflammation.
METHODS
The ELGAN study was designed to identify characteristics and exposures that increase the
risk of structural and functional neurologic disorders in ELGANs (the acronym for
Extremely Low Gestational Age Newborns). During the years 2002–2004, women
delivering before 28 weeks gestation at one of 14 participating institutions were asked to
enroll in the study. Each institution’s review board approved enrollment and consent
procedures and documents. A full description of the methods is provided elsewhere (37).
Here we focus on those most relevant to these analyses.
The sample for this report consists of the 805 newborns for whom we had information about
protein concentrations on at least two of the three protocol days (days 1, 7, and 14), who had
a developmental assessment at age 2 years post-term equivalent, and did not have a motor
handicap that might interfere in assessments of cognition (Table 1).
After delivery, a trained research nurse interviewed each mother in her native language
using a structured data collection form and following procedures defined in a manual.
Shortly after the mother’s discharge, the research nurse reviewed the maternal chart using a
second structured data collection form. The medical record was relied on for events
following admission.
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Definitions of pregnancy disorders that led to preterm delivery
The clinical circumstances that led to each maternal admission and ultimately to each
preterm delivery were operationally defined using both data from the maternal interview and
data abstracted from the medical record (38). Each mother/infant pair was assigned to the
category that described the primary reason for the preterm delivery. Preterm labor was
defined as progressive cervical dilation with regular contractions and intact membranes. The
diagnosis of preterm, premature rupture of fetal membranes (pPROM) was defined as the
presence of vaginal pooling with either documented nitrazine positive testing or ferning
prior to regular uterine activity. Preeclampsia was defined as new onset hypertension and
proteinuria of sufficient severity to warrant delivery for either a maternal or fetal indication.
A diagnosis of cervical insufficiency was made when a woman presented with cervical
dilation of greater than two centimeters, but no membrane rupture or perceived uterine
activity. Placental abruption was defined as appreciable vaginal bleeding (either documented
in the medical record or a post-partum hematocrit <24%) and a clinical diagnosis of
placental abruption in the absence of cervical change. Presentations under the category of
fetal indication included severe intrauterine growth restriction based on antepartum
ultrasound examination, non-reassuring fetal testing, oligohydramnious, and Doppler
abnormalities of umbilical cord blood flow.
Placenta bacteriology and morphology
Delivered placentas were placed in a sterile exam basin and transported to a sampling room,
where they were biopsied under sterile conditions and flash frozen. Eighty-two percent of
the samples were obtained within 1 hour of delivery. At a later time, the samples were
allowed to thaw at room temperature, a portion approximately 1 cm squared was removed
and weighed, then diluted 1:10 with sterile phosphate buffered saline (PBS), and
homogenized. Aliquots were plated on selective and non-selective media, including pre-
reduced Brucella-base agar with 5% sheep blood enriched with hemin and vitamin K1,
tryptic soy agar with 5% sheep blood, chocolate agar, and A-7 agar. After incubation, the
various colony types were enumerated, isolated and identified by established criteria.
For histologic evaluation, representative sections were taken from all abnormal areas as well
as routine sections from the umbilical cord and a membrane roll, and full thickness sections
from the center and a paracentral zone of the placental disc. After training to minimize
observer variability, study pathologists examined the slides for histologic characteristics
listed on a standardized data form they helped create (15,16). Briefly, infarcts and inter-
villous fibrin, fetal stem vessel thrombosis, and decidual hemorrhage and fibrin deposition
consistent with abruption were coded as present or absent. Chorionic villi were scored for
syncytial knots (none, occasional, or increased).
At the chorionic plate of the disc, grade 3 acute inflammation was defined as neutrophils up
to amnionic epithelium and stage 3 was defined as >20 neutrophils/20×). Grade 3
inflammation of the external membranes, as well as of the chorion/decidua required
numerous large or confluent foci of neutrophils.
Inflammation in the umbilical cord was graded from 0–5. Grade 3 required neutrophils in
perivascular Wharton’s jelly, grade 4 required panvasculitis and umbilical cord vasculitis
extending deep into Wharton’s jelly, and grade 5 required a ‘Halo lesion’ (ring of precipitate
in Wharton’s jelly encircling each vessel). Neutrophilic infiltration into fetal stem vessels in
the chorionic plate required that neutrophils appeared to have migrated towards the
amnionic cavity.
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Newborn variables
The gestational age estimates were based on a hierarchy of the quality of available
information. Most desirable were estimates based on the dates of embryo retrieval or
intrauterine insemination or fetal ultrasound before the 14th week (62%). When these were
not available, reliance was placed sequentially on a fetal ultrasound at 14 or more weeks
(29%), LMP without fetal ultrasound (7%), and gestational age recorded in the log of the
neonatal intensive care unit (1%).
A newborn was considered to be SGA if the birth weight was in the lowest decile of the
birth weight distribution in an external standard (19). This is equivalent to a birth weight
more than 1.28 standard deviations below the mean in a referent population.
Documented early bacteremia required recovery of an organism from blood drawn during
first postnatal week, and late bacteremia as recovery of an organism from blood drawn
during the second, third, or fourth week. Presumed bacteremia was defined as culture-
negative, but the clinician ordered antibiotics for more than 72 hours.
The lowest and highest arterial blood measurements of PaO2, PCO2, and pH on postnatal
days 1, 2, and 3 were routinely recorded. We identified ELGANs whose blood gas
measurements were in the extreme quartile for gestational age on at least two of the three
days.
Information about mode of ventilation was collected for every day during the first 7 days
and weekly thereafter until 28 days. ELGANs were classified into three mutually exclusive
groups: those with consistently low FiO2 (an FiO2 < 0.23 every day between postnatal days
3 and 7 and receiving FiO2 ≤ 0.25 on day 14), those with pulmonary deterioration (PD: an
FiO2 < 0.23 on any day between days 3 and 7 and receiving FiO2 > 0.25 on day 14), and
those with early and persistent pulmonary dysfunction (EPPD: an FiO2 ≥ 0.23 on all days
between 3 and 7 days of life and receiving FiO2 > 0.25 on day 14) 5.
24-month developmental assessment
Fully 91% of surviving children returned for a developmental assessment close to the time
when s/he would be 24-months corrected age. Of these children, 77% had their exam within
the range of 23.5–27.9 months. Most others were examined before 23.5 months.
Certified examiners administered and scored the Bayley Scales of Infant Development
Second Edition (39). We chose as our main outcome a Mental Development Index (MDI) <
55 because it is three standard deviations below the expected mean and therefore constitutes
a severe impairment, and because the predictive ability of an MDI < 55 is higher than that of
a score below 70, which is two standard deviations below the expected mean (40). Because
some MDI test items require intact motor function, we excluded all infants with significantly
impaired gross motor function, defined as an inability to walk independently (a Gross Motor
Function Classification System level ≥ 1), regardless of whether or not they were given a
cerebral palsy diagnosis.
Blood spot collection
After blood was collected for clinical indications, drops were blotted on filter paper on the
first postnatal day (range: 1–3 days), the 7th postnatal day (range: 5–8 days), and the 14th
postnatal day (range: 12–15 days). Dried blood spots were stored at −70°C in sealed bags
with desiccant until processed. All references below to protein concentrations refer to the 3
samples obtained on or about days 1, 7 and 14
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Protein measurement
Details about elution of proteins from blood spots and measurement of the proteins with the
Meso Scale Discovery (MSD) electrochemiluminescence system are provided elsewhere
(22). Inter-assay variations are invariably less than 20%. Measurements of each protein were
normalized to milligrams of total protein.
The Laboratory of Genital Tract Biology of the Department of Obstetrics, Gynecology and
Reproductive Biology at Brigham and Women’s Hospital, Boston measured the following
25 proteins: IL-1beta (Interleukin-1beta), IL-6 (Interleukin-6), IL-6R (interleukin-6
receptor), TNF-alpha (tumor necrosis factor-alpha), TNF-R1 (tumor necrosis factor-alpha-
receptor1), TNF-R2 (tumor necrosis factor-alpha-receptor2), IL-8 (CXCL8) (interleukin-8),
MCP-1 (CCL2) (monocyte chemotactic protein-1), MCP-4 (CCL13) (monocyte
chemoattractant protein-4) (CCL13), MIP-1beta (CCL4) (Macrophage Inflammatory
Protein-1beta) (CCL4), RANTES (CCL5) (regulated upon activation, normal T-cell
expressed, and [presumably] secreted), I-TAC (CXCL11) (Interferon-inducible T cell
Alpha-Chemoattractant), ICAM-1 (CD54) (intercellular adhesion molecule-1), ICAM-3
(CD50) (intercellular adhesion molecule-3), VCAM-1 (CD106) (vascular cell adhesion
molecule-1), E-SEL (CD62E) (E-selectin) (CD62E), MMP-1 (matrix metalloproteinase-1),
MMP-9 (matrix metalloproteinase-9), CRP (C-Reactive Protein), SAA (serum amyloid A),
MPO (myeloperoxidase). VEGF (vascular endothelial growth factor), VEGF-R1 (vascular
endothelial growth factor-receptor1), VEGF-R2 (vascular endothelial growth factor-
receptor2), and IGFBP-1 (Insulin Growth Factor Binding Protein-1).
In previous analyses in this sample, protein elevations in the top quartile (for gestational age
and postnatal day) on two separate days provided considerably more discriminating risk
information than did elevations on just one day (10–12). Thus, our indicator of postnatal
systemic inflammation is a concentration of an inflammation-related protein in the top
quartile that persisted or recurred.
Data analysis
We evaluated the following hypotheses about the risk of a low MDI, defined as either a very
low MDI (i.e., <55) or a moderately low MDI (i.e., between 55 and 69). First, compared to
ELGANs who were neither SGA nor had recurrent/persistent post-natal systemic
inflammation, those who had both characteristics were more likely to have a low MDI two
years later. Second, among ELGANS who were SGA, those who had recurrent/persistent
early post-natal systemic inflammation were much more likely to have a low MDI two years
later. Third, among ELGANS who had recurrent/persistent early post-natal systemic
inflammation, those who were SGA, were more likely to have a low MDI two years later.
Because our outcomes of interest (an MDI < 55 and an MDI 55–69) are mutually exclusive
and each is appropriately compared to the same referent group (MDI ≥ 70), we created
multinomial logistic regression models. This allowed us to calculate odds ratios and 99%
confidence intervals in separate models for each protein that included variables for SGA,
persistent/recurrent protein concentrations in the top quartile on two days a week apart, as
well as variables for gestational age (23–24, 25–26, and 27 weeks) and sex.
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Table 1
Sample description
Yes
Enrolled 1506
Survived to 2 years 1200
Bayley Scales of Infant Development assessment at age 2 years 1018
Gross Motor Function Classification System < 1 at 2 years 921
Proteins measured in blood collected on 2 or 3 days 805
 Mental Development Index (MDI) ≥ 70 629
 MDI ≥ 55, < 70 85
 MDI < 55 91
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